SOX2 and adrenal cortex carcinoma: As shown in the log-rank tests in Figure 4, overall survival (OS) and disease-free survival (DFS) of ACC patients with high SOX2 expression were lower than that of patients with low SOX2 expression (OS, p = 0.028; DFS, p = 0.048, respectively) (Figure 4).